Wall Street Breakfast Editors submit:
Top Stories
Thermo Fisher bids for Life Technologies. Thermo Fisher Scientific (TMO) reportedly made a binding offer of over $65 a share for genetic testing equipment maker Life Technologies (LIFE) ahead of a bid deadline yesterday. A consortium of private-equity firms, including Blackstone (BX), Carlyle (CG) and KKR (KKR), are also looking to make a proposal despite missing the deadline. Life’s shares closed at $66.19, giving it a market cap of $11.28B.
UnitedHealth hit with $500M jury verdict over hepatitis C cases. A Nevada jury has ordered UnitedHealth (UNH) to pay $500M in punitive damages for failing to properly supervise a doctor who has been blamed for causing two colonoscopy patients to contract hepatitis C by his reuse of anesthetic vials and failure to sterilize equipment. The award comes on top of $24M in compensation that UnitedHealth must pay, and could have wider implications for the healthcare industry.